Vivet Therapeutics Pipeline
| Drug | Indication | Phase |
|---|
| VTX-PID | Depletion of Neutralizing Antibodies against AAV | Phase 1/2 |
| VTX-801 | Wilson's Disease | Phase 1/2 |
| VTX-806 | Cerebrotendinous Xanthomatosis (CTX) | Preclinical |
| VTX-802 | Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC2) | Preclinical |